Expenditures have increased steadily relative to GDP in line with other European countries’ over the past two decades and reached 11% of GDP in 2015 (Figure 3, Panels A and B). Spending on in-patient curative and rehabilitative care and on medical goods, notably pharmaceuticals, are higher than the OECD average (Panels C and D). The authorities have undertaken several measures to improve controls on health spending and its efficiency.